This study, along with the relevance of TSP-1 to SS in humans, strongly supports the utility of TSP-1−/− mice as a suitable preclinical model to evaluate the therapeutic efficacy of novel treatments. This evidence concerns the gene THBS1 and synovial sarcoma.